Literature DB >> 12697428

What's new in neuro-oncology? Recent advances in medulloblastoma.

David W Ellison1, Steven C Clifford, Amar Gajjar, Richard J Gilbertson.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12697428     DOI： 10.1016/s1090-3798(03)00014-x

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN： 1090-3798            Impact factor:   3.140


× No keyword cloud information.
  32 in total

1.  Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.

Authors:  David W Ellison; Mehmet Kocak; James Dalton; Hisham Megahed; Meryl E Lusher; Sarra L Ryan; Wei Zhao; Sarah Leigh Nicholson; Roger E Taylor; Simon Bailey; Steven C Clifford
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

2.  Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma.

Authors:  Adam W Studebaker; Brian Hutzen; Christopher R Pierson; Stephen J Russell; Evanthia Galanis; Corey Raffel
Journal:  Neuro Oncol       Date:  2012-02-03       Impact factor: 12.300

3.  Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003.

Authors:  D Kombogiorgas; S Sgouros; A R Walsh; A D Hockley; M Stevens; R Grundy; A Peet; M English; D Spooner
Journal:  Childs Nerv Syst       Date:  2006-11-22       Impact factor: 1.475

Review 4.  Embryonic tumours of the central nervous system.

Authors:  Aurora Navajas Gutiérrez; Ana Fernández-Teijeiro Alvarez
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

5.  Detection of drug-induced cellular changes using confocal Raman spectroscopy on patterned single-cell biosensors.

Authors:  Ryan Buckmaster; Fareid Asphahani; Myo Thein; Jian Xu; Miqin Zhang
Journal:  Analyst       Date:  2009-04-30       Impact factor: 4.616

Review 6.  Childhood medulloblastoma: current status of biology and treatment.

Authors:  Laura J Klesse; Daniel C Bowers
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

7.  Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human.

Authors:  Xuqun Tang; Yu Yao; Jingjing Zhu; Kunlin Jin; Yin Wang; Ying Mao; Liangfu Zhou
Journal:  Childs Nerv Syst       Date:  2012-07-20       Impact factor: 1.475

8.  Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.

Authors:  Jennifer A Anderton; Janet C Lindsey; Meryl E Lusher; Richard J Gilbertson; Simon Bailey; David W Ellison; Steven C Clifford
Journal:  Neuro Oncol       Date:  2008-07-29       Impact factor: 12.300

9.  Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion.

Authors:  Lowell Evan Michael; Bart A Westerman; Alexandre N Ermilov; Aiqin Wang; Jennifer Ferris; Jianhong Liu; Marleen Blom; David W Ellison; Maarten van Lohuizen; Andrzej A Dlugosz
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

10.  Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.

Authors:  Yuan Lu; Sarra L Ryan; David J Elliott; Graham R Bignell; P Andrew Futreal; David W Ellison; Simon Bailey; Steven C Clifford
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.